Enhancing the anti-tumor immunity and therapeutic potential of ICT01, a butyrophilin3A-targeted, &gamma;9&delta;2 T cell-activating monoclonal antibody, with low dose IL-2 in patients with advanced solid tumors: The EVICTION-2 trial
ICT01;IL-2
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Enhancing the anti-tumor immunity and therapeutic potential of ICT01, a butyrophilin3A-targeted, &gamma;9&delta;2 T cell-activating monoclonal antibody, with low dose IL-2 in patients with advanced solid tumors: The EVICTION-2 trial ### Output: ICT01;IL-2